HomeCompareCKHUY vs PFE

CKHUY vs PFE: Dividend Comparison 2026

CKHUY yields 2.94% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $28.5K in total portfolio value· pulled ahead in Year 9
10 years
CKHUY
CKHUY
● Live price
2.94%
Share price
$7.70
Annual div
$0.23
5Y div CAGR
-23.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$20.82
Full CKHUY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CKHUY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCKHUYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CKHUY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CKHUY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CKHUY
Annual income on $10K today (after 15% tax)
$250.25/yr
After 10yr DRIP, annual income (after tax)
$17.70/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,302.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CKHUY + PFE for your $10,000?

CKHUY: 50%PFE: 50%
100% PFE50/50100% CKHUY
Portfolio after 10yr
$35.3K
Annual income
$13,139.77/yr
Blended yield
37.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CKHUY
No analyst data
Altman Z
1.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CKHUY buys
0
PFE buys
0
No recent congressional trades found for CKHUY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCKHUYPFE
Forward yield2.94%6.13%
Annual dividend / share$0.23$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-23.8%13.2%
Portfolio after 10y$21.1K$49.6K
Annual income after 10y$20.82$26,258.71
Total dividends collected$909.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CKHUY vs PFE ($10,000, DRIP)

YearCKHUY PortfolioCKHUY Income/yrPFE PortfolioPFE Income/yrGap
1$10,924$224.34$9,153$693.39+$1.8KCKHUY
2$11,864$174.53$8,593$849.25+$3.3KCKHUY
3$12,829$134.98$8,336$1,066.78+$4.5KCKHUY
4$13,831$103.95$8,437$1,384.80+$5.4KCKHUY
5$14,879$79.81$9,013$1,875.40+$5.9KCKHUY
6$15,982$61.14$10,306$2,680.72+$5.7KCKHUY
7$17,147$46.77$12,820$4,101.38+$4.3KCKHUY
8$18,383$35.74$17,673$6,826.70+$710.00CKHUY
9← crossover$19,697$27.28$27,543$12,591.86$7.8KPFE
10$21,097$20.82$49,560$26,258.71$28.5KPFE

CKHUY vs PFE: Complete Analysis 2026

CKHUYStock

CK Hutchison Holdings Limited, an investment holding company, operates in ports and related services, retail, infrastructure, and telecommunications businesses worldwide. The company invests in, develops, and operates ports, which operate 291 berths in 52 ports spanning 26 countries; and provides logistics and transportation-related services, such as cruise ship terminals, distribution centers, rail services, and ship repair facilities. It also operates 12 retail brands with 16,398 stores that offer personal care, health and beauty products, food and fine wines, consumer electronics, and electrical appliances in Asia and Europe, as well as operates supermarkets; and manufactures and distributes bottled water and other beverages under the Watsons Water and Mr. Juicy brands in Hong Kong and Mainland China. In addition, the company invests in energy infrastructure, transportation infrastructure, water infrastructure, waste management, waste-to-energy, household infrastructure, and other infrastructure related businesses primarily in Hong Kong, Mainland China, the United Kingdom, Continental Europe, Australia, New Zealand, Canada, and the United States. Further, it provides mobile telecommunications and data services, as well as operates as an integrated energy company in the United States, Canada, and the Asia Pacific. Additionally, it researches, develops, manufactures, commercializes, markets, and sells nutraceuticals, pharmaceuticals, and agriculture-related products; provides marine construction and ship repair yard, water supply and sewerage, electricity generation and distribution, gas distribution, and aircraft maintenance services; and leases rolling stocks. CK Hutchison Holdings Limited was founded in 1828 and is based in Central, Hong Kong.

Full CKHUY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CKHUY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CKHUY vs SCHDCKHUY vs JEPICKHUY vs OCKHUY vs KOCKHUY vs MAINCKHUY vs JNJCKHUY vs MRKCKHUY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.